Profile data is unavailable for this security.
About the company
Coloplast A/S is a Denmark-based company active within the healthcare sector. It is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature. Its operations are structured into four business areas: Ostomy Care offering products for people whose intestinal outlet has been rerouted through the abdominal wall, Continence Care products for people suffering from diseases of and damage to the urinary system, Urology Care products for people suffering from diseases of and damage to the kidneys, the urinary system or the male reproductive system and Wound & Skin Care for the treatment of chronic wounds and skin care products for prevention and treatment. The Company supplies products to hospitals, institutions as well as wholesalers and pharmacies.
- Revenue in DKK (TTM)27.79bn
- Net income in DKK4.54bn
- Incorporated1957
- Employees16.74k
- LocationColoplast A/SHoltedam 1-3HUMLEBAEK 3050DenmarkDNK
- Phone+45 49111111
- Fax+45 49111555
- Websitehttps://www.coloplast.dk/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Smith & Nephew plc | 37.09bn | 2.63bn | 85.20bn | 17.35k | 32.39 | 2.53 | 12.63 | 2.30 | 0.3485 | 0.3485 | 4.91 | 4.46 | 0.5713 | 0.7378 | 4.33 | 248,086.20 | 4.05 | 3.62 | 4.98 | 4.41 | 69.64 | 70.47 | 7.09 | 7.10 | 1.33 | 6.42 | 0.3868 | 87.54 | 4.70 | 2.49 | 56.65 | -7.24 | -1.36 | -2.01 |
| BioMerieux SA | 29.70bn | 3.23bn | 105.37bn | 14.75k | 32.78 | 3.35 | 18.82 | 3.55 | 3.64 | 3.64 | 33.51 | 35.66 | 0.7217 | 1.81 | 5.23 | 269,750.60 | 7.71 | 9.22 | 9.66 | 11.94 | 55.66 | 56.58 | 10.68 | 12.35 | 1.29 | 29.74 | 0.1044 | 20.24 | 8.31 | 8.27 | 20.86 | 9.64 | 4.88 | 36.49 |
| Sonova Holding AG | 30.98bn | 4.33bn | 110.86bn | 17.99k | 25.66 | 5.19 | 17.39 | 3.58 | 9.04 | 9.04 | 64.66 | 44.70 | 0.6599 | 2.36 | 6.93 | 214,863.80 | 9.34 | 10.74 | 12.11 | 13.66 | 72.43 | 72.16 | 14.15 | 17.50 | 0.9618 | 18.80 | 0.3514 | 42.61 | 6.58 | 5.79 | -10.07 | 5.22 | 1.33 | -- |
| Sartorius AG | 25.70bn | 712.63m | 110.89bn | 13.57k | 126.93 | 4.49 | 25.62 | 4.31 | 1.39 | 1.39 | 50.31 | 39.25 | 0.3321 | 2.08 | 9.50 | 254,590.50 | 1.51 | 6.19 | 2.00 | 8.65 | 45.27 | 49.69 | 4.54 | 12.35 | 0.9259 | 2.83 | 0.5468 | 22.30 | -0.4417 | 13.10 | -59.14 | -11.72 | 12.69 | 15.84 |
| Coloplast A/S | 27.79bn | 4.54bn | 126.16bn | 16.74k | 29.75 | 7.98 | 21.46 | 4.54 | 20.17 | 20.17 | 123.39 | 75.18 | 0.5714 | 2.45 | 5.92 | 1,710,716.00 | 9.34 | 16.21 | 13.17 | 22.91 | 67.52 | 67.85 | 16.35 | 21.02 | 0.6082 | 8.87 | 0.5889 | 92.23 | 10.33 | 8.54 | 5.62 | 5.46 | 14.30 | 5.29 |
| Straumann Holding AG | 20.07bn | 3.67bn | 133.15bn | 11.82k | 36.33 | 8.14 | 27.49 | 6.64 | 2.87 | 2.43 | 15.69 | 12.79 | 0.7215 | 1.79 | 4.28 | 211,925.50 | 13.24 | 12.06 | 17.41 | 15.54 | 71.40 | 74.11 | 18.35 | 17.39 | 1.15 | 15.33 | 0.1871 | 32.23 | 9.98 | 9.42 | 2.11 | 8.35 | 2.28 | 10.56 |
| Koninklijke Philips NV | 134.17bn | 1.78bn | 147.73bn | 67.25k | 82.22 | 1.63 | 14.08 | 1.10 | 0.25 | 0.3934 | 19.22 | 12.64 | -- | -- | -- | 265,101.80 | -- | -0.8858 | -- | -1.21 | 43.42 | 44.38 | 1.31 | -1.47 | 0.7901 | 4.31 | 0.3922 | -- | -0.8146 | 0.9993 | -85.09 | -- | -6.60 | -- |
| Sartorius Stedim Biotech SA | 21.32bn | 1.52bn | 147.94bn | 9.96k | 96.58 | 4.99 | 38.48 | 6.94 | 2.11 | 2.11 | 29.48 | 40.83 | 0.3414 | 2.06 | 9.53 | 288,627.40 | 2.47 | 8.62 | 2.80 | 10.54 | 43.89 | 49.34 | 7.23 | 15.34 | 1.14 | 3.53 | 0.4226 | 20.94 | 0.1621 | 14.05 | -43.57 | -5.67 | 20.10 | 15.21 |
| Holder | Shares | % Held |
|---|---|---|
| Fundsmith LLPas of 28 Feb 2025 | 7.67m | 3.65% |
| The Vanguard Group, Inc.as of 02 Jul 2025 | 4.70m | 2.24% |
| Norges Bank Investment Managementas of 31 Dec 2024 | 2.86m | 1.36% |
| Comgest SAas of 30 May 2025 | 2.82m | 1.34% |
| BlackRock Fund Advisorsas of 03 Jul 2025 | 2.38m | 1.13% |
| Handelsbanken Fonder ABas of 30 Jun 2025 | 2.00m | 0.95% |
| Walter Scott & Partners Ltd.as of 03 Jul 2025 | 1.63m | 0.78% |
| Allianz Global Investors GmbHas of 30 May 2025 | 1.34m | 0.64% |
| Geode Capital Management LLCas of 04 Jul 2025 | 1.33m | 0.63% |
| BlackRock Advisors (UK) Ltd.as of 04 Jul 2025 | 1.31m | 0.63% |
